| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1014183880 |
| P356 | DOI | 10.1007/S12016-015-8466-Y |
| P8608 | Fatcat ID | release_63y6n3myrzbebfxfwwgu6w5mp4 |
| P698 | PubMed publication ID | 25663566 |
| P5875 | ResearchGate publication ID | 272098219 |
| P2093 | author name string | Ping Huang | |
| Pu Li | |||
| Fei Li | |||
| Ye Yang | |||
| Mu Hao | |||
| Hongwei Peng | |||
| P2860 | cites work | Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome | Q24623046 |
| Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS) | Q24623371 | ||
| Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop | Q24632569 | ||
| How I treat autoimmune lymphoproliferative syndrome | Q24633207 | ||
| Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS) | Q24643047 | ||
| Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome | Q24650472 | ||
| Autoimmune lymphoproliferative syndrome: an update and review of the literature | Q26825740 | ||
| Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency | Q28204372 | ||
| A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome | Q28215936 | ||
| A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation | Q28246980 | ||
| Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome | Q28248908 | ||
| Autoimmune lymphoproliferative syndrome with somatic Fas mutations | Q28285625 | ||
| Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS) | Q28293136 | ||
| Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis | Q28299956 | ||
| Chronic lymphadenopathy simulating malignant lymphoma | Q59242110 | ||
| Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer | Q73783297 | ||
| TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis | Q74401877 | ||
| The broad spectrum of autoimmune lymphoproliferative disease: molecular bases, clinical features and long-term follow-up in 31 patients | Q82825337 | ||
| Causes and consequences of the autoimmune lymphoproliferative syndrome | Q28300792 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome | Q33328425 | ||
| Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa. | Q33394404 | ||
| Pentostatin for treatment of refractory autoimmune lymphoproliferative syndrome | Q33394927 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. | Q33498995 | ||
| Autoimmune lymphoproliferative syndrome, a disorder of apoptosis | Q33790355 | ||
| Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome | Q33944255 | ||
| The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis | Q33952333 | ||
| Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival | Q34114550 | ||
| Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. | Q34148939 | ||
| Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis | Q34149957 | ||
| New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome | Q34239719 | ||
| Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype | Q34513178 | ||
| Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells | Q34552979 | ||
| Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice | Q34570268 | ||
| Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome | Q34809111 | ||
| Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management | Q35074313 | ||
| A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease | Q35604700 | ||
| NRAS mutation causes a human autoimmune lymphoproliferative syndrome. | Q35829141 | ||
| Elevated vitamin B₁₂ levels in autoimmune lymphoproliferative syndrome attributable to elevated haptocorrin in lymphocytes | Q35840445 | ||
| In utero and early postnatal presentation of autoimmune lymphoproliferative syndrome in a family with a novel FAS mutation | Q36862548 | ||
| Measurement of apoptosis and other forms of cell death | Q37146450 | ||
| Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS) | Q37219274 | ||
| Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. | Q37363074 | ||
| Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations | Q37670054 | ||
| Advances in autoimmune lymphoproliferative syndromes | Q37859077 | ||
| Autoimmune lymphoproliferative syndrome mimicking chronic active Epstein-Barr virus infection. | Q40323202 | ||
| A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect | Q42656563 | ||
| Autoimmune lymphoproliferative syndrome: response to mycophenolate mofetil and pyrimethamine/sulfadoxine in a 5-year-old child | Q42810256 | ||
| Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients | Q43460814 | ||
| Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells | Q43641873 | ||
| Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin | Q47812587 | ||
| The autoimmune lymphoproliferative syndrome (Canale-Smith) in adulthood. | Q55038036 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| P433 | issue | 1 | |
| P921 | main subject | autoimmune lymphoproliferative syndrome | Q1151300 |
| P304 | page(s) | 55-63 | |
| P577 | publication date | 2015-02-08 | |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS). | |
| P478 | volume | 50 |
| Q48283620 | A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats |
| Q39016299 | An Update on the Use of Immunomodulators in Primary Immunodeficiencies |
| Q64059809 | Case report of a molar-root incisor malformation in a patient with an autoimmune lymphoproliferative syndrome |
| Q41153268 | Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis. |
| Q39251222 | Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance. |
| Q89491144 | Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases: A Single Center Experience |
| Q33439759 | Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome |
| Q39413866 | Small molecules to the rescue: Inhibition of cytokine signaling in immune-mediated diseases |
| Q47136733 | Stabilized β-Catenin Ameliorates ALPS-Like Symptoms of B6/lpr Mice |
| Q40202981 | T and B cell clonal expansion in Ras-associated lymphoproliferative disease (RALD) as revealed by next-generation sequencing. |
| Q39609044 | TCF1 deficiency ameliorates autoimmune lymphoproliferative syndrome (ALPS)-like phenotypes of lpr/lpr mice. |
| Q41487980 | The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach |
| Q33437659 | Unexplained lymphadenopathies: autoimmune lymphoproliferative syndrome in an adult patient |
Search more.